Format
Sort by

Send to

Choose Destination

Links from

Items: 1 to 20 of 32

1.

The Vaccine Candidate Substrate Binding Protein SBP2 Plays a Key Role in Arginine Uptake, Which Is Required for Growth of Moraxella catarrhalis.

Otsuka T, Kirkham C, Brauer A, Koszelak-Rosenblum M, Malkowski MG, Murphy TF.

Infect Immun. 2015 Nov 23;84(2):432-8. doi: 10.1128/IAI.00799-15.

2.

Poor memory B cell generation contributes to non-protective responses to DTaP vaccine antigens in otitis-prone children.

Basha S, Pichichero ME.

Clin Exp Immunol. 2015 Dec;182(3):314-22. doi: 10.1111/cei.12660. Epub 2015 Sep 30.

PMID:
26138025
3.

Association of pneumococcal conjugate vaccination with rates of ventilation tube insertion in Denmark: population-based register study.

Groth C, Thomsen RW, Ovesen T.

BMJ Open. 2015 Jun 5;5(6):e007151. doi: 10.1136/bmjopen-2014-007151.

4.

Impact of pneumococcal conjugate vaccine on pediatric tympanostomy tube insertion in partial immunized population.

Wang MC, Wang YP, Chu CH, Tu TY, Shiao AS, Chou P.

ScientificWorldJournal. 2015;2015:248678. doi: 10.1155/2015/248678. Epub 2015 Mar 9.

5.

Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children.

Ren D, Almudevar AL, Pichichero ME.

Hum Vaccin Immunother. 2015;11(2):489-97. doi: 10.4161/21645515.2014.990861.

6.

What is behind the ear drum? The microbiology of otitis media and the nasopharyngeal flora in children in the era of pneumococcal vaccination.

Mills N, Best EJ, Murdoch D, Souter M, Neeff M, Anderson T, Salkeld L, Ahmad Z, Mahadevan M, Barber C, Brown C, Walker C, Walls T.

J Paediatr Child Health. 2015 Mar;51(3):300-6. doi: 10.1111/jpc.12710. Epub 2014 Sep 1.

7.

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?

Torres A, Bonanni P, Hryniewicz W, Moutschen M, Reinert RR, Welte T.

Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):19-31. doi: 10.1007/s10096-014-2208-6. Epub 2014 Aug 23. Review. Erratum in: Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):415-6.

8.

Epidemiology of pneumococcal disease in a national cohort of older adults.

Morrill HJ, Caffrey AR, Noh E, LaPlante KL.

Infect Dis Ther. 2014 Jun;3(1):19-33. doi: 10.1007/s40121-014-0025-y. Epub 2014 Apr 12.

9.

The protective effect of adenoidectomy on pediatric tympanostomy tube re-insertions: a population-based birth cohort study.

Wang MC, Wang YP, Chu CH, Tu TY, Shiao AS, Chou P.

PLoS One. 2014 Jul 1;9(7):e101175. doi: 10.1371/journal.pone.0101175. eCollection 2014.

10.

Substrate binding protein SBP2 of a putative ABC transporter as a novel vaccine antigen of Moraxella catarrhalis.

Otsuka T, Kirkham C, Johnson A, Jones MM, Murphy TF.

Infect Immun. 2014 Aug;82(8):3503-12. doi: 10.1128/IAI.01832-14. Epub 2014 Jun 9.

11.

Payment analysis of two diagnosis and management approaches of acute otitis media.

Casey JR, Pichichero ME.

Clin Pediatr (Phila). 2014 Aug;53(9):865-73. doi: 10.1177/0009922814533592. Epub 2014 May 9.

12.

What does tympanostomy tube placement in children teach us about the association between atopic conditions and otitis media?

Juhn YJ, Wi CI.

Curr Allergy Asthma Rep. 2014 Jul;14(7):447. doi: 10.1007/s11882-014-0447-3. Review.

13.

Oral administration of herbal medicines for the treatment of otitis media with effusion: protocol for a systematic review.

Kim YH, Son MJ, Kim YE, Lee HW, Lee MS.

BMJ Open. 2014 Feb 27;4(2):e004095. doi: 10.1136/bmjopen-2013-004095. Review.

14.

Cellular immune response in young children accounts for recurrent acute otitis media.

Sharma SK, Pichichero ME.

Curr Allergy Asthma Rep. 2013 Oct;13(5):495-500. Review.

15.

A genome-wide association study of chronic otitis media with effusion and recurrent otitis media identifies a novel susceptibility locus on chromosome 2.

Allen EK, Chen WM, Weeks DE, Chen F, Hou X, Mattos JL, Mychaleckyj JC, Segade F, Casselbrant ML, Mandel EM, Ferrell RE, Rich SS, Daly KA, Sale MM.

J Assoc Res Otolaryngol. 2013 Dec;14(6):791-800. doi: 10.1007/s10162-013-0411-2. Epub 2013 Aug 23.

16.

Relationship with original pathogen in recurrence of acute otitis media after completion of amoxicillin/clavulanate: bacterial relapse or new pathogen.

Kaur R, Casey JR, Pichichero ME.

Pediatr Infect Dis J. 2013 Nov;32(11):1159-62. doi: 10.1097/INF.0b013e31829e3779.

17.

Panel 6: Vaccines.

Pelton SI, Pettigrew MM, Barenkamp SJ, Godfroid F, Grijalva CG, Leach A, Patel J, Murphy TF, Selak S, Bakaletz LO.

Otolaryngol Head Neck Surg. 2013 Apr;148(4 Suppl):E90-101. doi: 10.1177/0194599812466535. Review.

18.

Reducing the frequency of acute otitis media by individualized care.

Pichichero ME, Casey JR, Almudevar A.

Pediatr Infect Dis J. 2013 May;32(5):473-8. doi: 10.1097/INF.0b013e3182862b57.

19.

Pneumococcal conjugate vaccines and otitis media.

Taylor S, Marchisio P, Vergison A, Hausdorff WP, Haggard M.

Int J Otolaryngol. 2012;2012:764573. doi: 10.1155/2012/764573. Epub 2012 Nov 13. No abstract available.

20.

The impact of new vaccine introduction on immunization and health systems: a review of the published literature.

Hyde TB, Dentz H, Wang SA, Burchett HE, Mounier-Jack S, Mantel CF; New Vaccine Introduction Impact Published Literature Working Group.

Vaccine. 2012 Oct 5;30(45):6347-58. doi: 10.1016/j.vaccine.2012.08.029. Epub 2012 Aug 29. Review.

Items per page

Supplemental Content

Write to the Help Desk